-
vTv Therapeutics Shares Rise 50% After Setting A Date To Report Alzheimer's Trial Results
Wednesday, October 17, 2018 - 10:02am | 347Shares of clinical-stage pharmaceutical company vTv Therapeutics Inc. (NASDAQ: VTVT) surged 50 percent Wednesday morning. What Happened The company is engaged in the research and development of treatments for Alzheimer’s disease and diabetes. This week, it announced the delivery of an...